Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q1 2026 Earnings

26FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.16

-0.15

-0.13

-0.12

Details

Expected EPS

-0.144725

Actual EPS

-0.16

Surprise EPS

-0.02

Surprise Percent

+10.55%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.16 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.